You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 27, 2025

Drug Price Trends for NDC 69238-1564


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 69238-1564

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
AMPHETAMINE SO4 10MG TAB AvKare, LLC 69238-1564-01 100 64.76 0.64760 2023-06-15 - 2028-06-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 1 of 1 entries

Market Analysis and Price Projections for Amphetamine Sulfate (NDC: 69238-1564)

Amphetamine Sulfate, marketed under NDC 69238-1564, is a prescription drug manufactured by Amneal Pharmaceuticals NY LLC. This central nervous system stimulant, available as an oral tablet, plays a significant role in the pharmaceutical market. Let's delve into a comprehensive market analysis and explore price projections for this drug.

Drug Overview

Amphetamine Sulfate (NDC: 69238-1564) is a human prescription drug approved by the FDA[1]. Key details include:

  • Proprietary Name: Amphetamine Sulfate
  • Generic Name: Amphetamine
  • Dosage Form: Tablet
  • Route of Administration: Oral
  • Marketing Start Date: September 28, 2018
  • Marketing Category: ANDA (Abbreviated New Drug Application)
  • Application Number: ANDA211139
  • Active Ingredient Strength: 10 mg/1
  • DEA Schedule: CII

Current Market Landscape

The pharmaceutical industry is undergoing significant changes, with 2025 expected to be a pivotal year for progress[3]. Key trends shaping the market include:

  1. AI-driven drug discovery
  2. Increased patient engagement through telehealth and wearables
  3. Strategic mergers and acquisitions
  4. Management of industry headwinds

AI in Drug Discovery

By 2025, artificial intelligence is projected to drive 30% of new drug discoveries, potentially reducing costs and accelerating the development of personalized treatments[3]. This technological advancement could impact the production and pricing of drugs like Amphetamine Sulfate.

Patient Engagement

The rise of telehealth, wearables, and home care is giving patients more control over their health management[3]. This trend could influence the demand for prescription drugs and potentially affect pricing strategies.

Pricing Dynamics in the U.S. Pharmaceutical Market

Understanding the broader pricing dynamics in the U.S. pharmaceutical market is crucial for projecting the price of Amphetamine Sulfate.

U.S. vs. International Prices

In 2022, U.S. prices across all drugs (brands and generics) were nearly three times as high as prices in 33 OECD comparison countries[4]. For every dollar paid in other countries for drugs, U.S. consumers pay $2.78. This price gap has been widening over time.

U.S. prices for brand drugs were 422 percent of prices in the comparison countries, or at least 322 percent if we adjust for estimated rebates in the U.S., but not for estimated rebates in other countries (for which data are generally unavailable)[4].

Generic Drug Pricing

Interestingly, U.S. prices for unbranded generics were lower than prices in comparison countries. For every dollar other countries pay on average for these drugs, U.S. consumers pay 67 cents[4]. This is particularly relevant for Amphetamine Sulfate, which is marketed under an ANDA.

Price Change Trends

Recent data on prescription drug price changes provide insights into potential future pricing for Amphetamine Sulfate:

  • From January 2022 to January 2023, more than 4,200 drug products had price increases, with 46% larger than the inflation rate[6].
  • The average drug price increase over this period was 15.2%, translating to $590 per drug product[6].
  • Multi-source drugs (like generics) tend to have higher percentage price increases but lower absolute dollar increases compared to single-source drugs[6].

Factors Influencing Future Pricing

Several factors could influence the future pricing of Amphetamine Sulfate:

1. Medicare Drug Price Negotiation Program

The Medicare Drug Price Negotiation Program, set to begin in 2026, could impact drug pricing across the board[2]. While Amphetamine Sulfate may not be directly affected in the first round of negotiations, the program's ripple effects could influence its pricing.

2. Market Competition

The level of competition in the prescription drug market significantly impacts pricing power[9]. As Amphetamine Sulfate is a generic drug, its pricing may be influenced by the number of manufacturers producing similar products.

3. Policy and Regulatory Changes

Potential policy changes under new administrations could affect drug pricing strategies[7]. Pharmaceutical companies will need to adapt to evolving health policies, tariffs, taxes, and M&A oversight.

4. Technological Advancements

The increasing role of AI in drug discovery and development could potentially lower production costs, which might translate to lower prices for consumers[3].

Price Projections for Amphetamine Sulfate (NDC: 69238-1564)

While exact price projections are challenging due to the complex and dynamic nature of the pharmaceutical market, we can make some educated estimates based on current trends:

  1. Short-term (1-2 years): Given the average price increase of 15.2% observed in 2022-2023[6], we might expect a similar trend for Amphetamine Sulfate. However, as a generic drug, its price increases may be more moderate.

  2. Medium-term (3-5 years): The implementation of the Medicare Drug Price Negotiation Program in 2026[2] could create downward pressure on drug prices overall. This might lead to more modest price increases or even price stabilization for drugs like Amphetamine Sulfate.

  3. Long-term (5+ years): Technological advancements, particularly in AI-driven drug discovery[3], could potentially lower production costs. This might translate to more competitive pricing in the generic drug market, including for Amphetamine Sulfate.

Strategies for Stakeholders

Given these projections, various stakeholders in the pharmaceutical industry should consider the following strategies:

For Manufacturers

  1. Invest in AI and other technologies to optimize production processes and reduce costs.
  2. Monitor policy changes closely and adapt pricing strategies accordingly.
  3. Consider strategic partnerships or M&As to strengthen market position.

For Healthcare Providers

  1. Stay informed about price changes and their potential impact on patient care.
  2. Explore telehealth and other patient engagement technologies to improve care delivery.

For Patients

  1. Discuss generic alternatives with healthcare providers when appropriate.
  2. Stay informed about patient assistance programs and other resources for managing medication costs.

Key Takeaways

  1. Amphetamine Sulfate (NDC: 69238-1564) is a generic prescription drug in a dynamic and evolving market.
  2. U.S. drug prices are significantly higher than in other countries, but generic drugs tend to be more competitively priced.
  3. The Medicare Drug Price Negotiation Program, set to begin in 2026, could have far-reaching effects on drug pricing.
  4. Technological advancements, particularly in AI, could potentially lower drug production costs in the long term.
  5. Stakeholders should stay informed about market trends and policy changes to make informed decisions.

FAQs

  1. Q: How does the pricing of Amphetamine Sulfate compare to brand-name alternatives? A: As a generic drug, Amphetamine Sulfate is likely to be priced lower than brand-name alternatives. In the U.S., generic drugs are generally priced more competitively compared to international markets.

  2. Q: Will the Medicare Drug Price Negotiation Program directly affect the price of Amphetamine Sulfate? A: While Amphetamine Sulfate may not be directly negotiated in the first round, the program could have indirect effects on the overall drug pricing landscape, potentially influencing its price.

  3. Q: How might AI impact the future pricing of drugs like Amphetamine Sulfate? A: AI is expected to drive 30% of new drug discoveries by 2025, potentially reducing production costs. This could lead to more competitive pricing in the generic drug market, including for drugs like Amphetamine Sulfate.

  4. Q: What factors should patients consider when evaluating the cost of Amphetamine Sulfate? A: Patients should consider factors such as insurance coverage, patient assistance programs, and the availability of alternative generic options. Discussing these factors with healthcare providers can help in making informed decisions.

  5. Q: How often do drug prices typically change? A: Drug manufacturers can change prices at any time, but significant changes are often observed annually. From January 2022 to January 2023, over 4,200 drug products had price increases, with an average increase of 15.2%.

Sources cited:

  1. https://fda.report/NDC/69238-1564
  2. https://www.weforum.org/stories/2025/01/2025-can-be-a-pivotal-year-of-progress-for-pharma/
  3. https://aspe.hhs.gov/sites/default/files/documents/277371265a705c356c968977e87446ae/international-price-comparisons.pdf
  4. https://aspe.hhs.gov/sites/default/files/documents/0cdd88059165eef3bed1fc587a0fd68a/aspe-drug-price-tracking-brief.pdf
  5. https://www.pwc.com/us/en/industries/pharma-life-sciences/pharmaceutical-industry-trends.html
  6. https://aspe.hhs.gov/reports/competition-prescription-drug-markets

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.